Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy

To determine whether treatment with the anti-TNF-alpha blocker adalimumab yields persistent improvement of endothelial function and prevents from morphological progression of subclinical atherosclerosis in patients with rheumatoid arthritis (RA) refractory to conventional therapy, a series of 34 con...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Juanatey, Carlos, Vazquez-Rodriguez, Tomas R., Miranda-Filloy, Jose A., Gomez-Acebo, Ines, Testa, Ana, Garcia-Porrua, Carlos, Sanchez-Andrade, Amalia, Llorca, Javier, González-Gay, Miguel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415105/
https://www.ncbi.nlm.nih.gov/pubmed/22899879
http://dx.doi.org/10.1155/2012/674265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415105/
https://www.ncbi.nlm.nih.gov/pubmed/22899879
http://dx.doi.org/10.1155/2012/674265

Ejemplares similares